Aldeyra Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Aldeyra Therapeutics (ALDX) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Aldeyra Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aldeyra Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aldeyra Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $96k | 18k | 5.22 |
| 2025-06-30 | $109k | 28k | 3.83 |
| 2025-03-31 | $162k | 28k | 5.75 |
| 2024-12-31 | $143k | 29k | 4.99 |
| 2024-09-30 | $155k | 29k | 5.39 |
| 2024-06-30 | $95k | 29k | 3.31 |
| 2023-12-31 | $87k | 25k | 3.51 |
| 2023-09-30 | $165k | 25k | 6.68 |
| 2023-06-30 | $207k | 25k | 8.39 |
| 2022-03-31 | $64k | 14k | 4.45 |
| 2021-12-31 | $75k | 19k | 4.00 |
| 2021-09-30 | $83k | 9.4k | 8.78 |
| 2021-06-30 | $216k | 19k | 11.33 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors